---
title: View of Field | regulatory
description: regulatory | QUEL Imaging's observations of challenges with in vivo fluorescence imaging. How can phantoms and reference targets be used to advance the field?
---

[Skip to content](https://blog.quelimaging.com/tag/regulatory#main-content)

[![QUEL\_web\_logo-1](https://blog.quelimaging.com/hs-fs/hubfs/QUEL_web_logo-1.png?width=200&height=75&name=QUEL_web_logo-1.png)](https://www.QUELimaging.com)

- [Home](https://blog.quelimaging.com)
- [Products](https://shop.QUELimaging.com)
- [Blog](https://blog.quelimaging.com)
- [News](https://www.QUELimaging.com/news)
- [About](https://www.quelimaging.com/about)
- [Resources](https://shop.QUELimaging.com/Resources)

Open main navigation

Close main navigation

- [Home](https://blog.quelimaging.com)
- [Products](https://shop.QUELimaging.com)
- [Blog](https://blog.quelimaging.com)
- [News](https://www.QUELimaging.com/news)
- [About](https://www.quelimaging.com/about)
- [Resources](https://shop.QUELimaging.com/Resources)

# View of Field

### Reflections on the field of *in vivo* fluorescence imaging

[![QUEL Q logo on image of Stanford'sLi Ka Shing Center](https://blog.quelimaging.com/hubfs/Stanford_Q.jpg)](https://blog.quelimaging.com/barth-reimbursement-strategy-2026-01)

[clinical translation](https://blog.quelimaging.com/tag/clinical-translation)

### [Charting a Course: Reimbursement Strategy for Optical Imaging Agents](https://blog.quelimaging.com/barth-reimbursement-strategy-2026-01)

![Picture of Ethan LaRochelle](https://app.hubspot.com/settings/avatar/925081a77283a399dbd145b49b251212) [Ethan LaRochelle](https://blog.quelimaging.com/author/ethan)

At the [2026 Stanford Symposium on Optical Surgical Navigation](https://www.onlineregistrationcenter.com/register/222/page1.asp?m=286&c=51), two consecutive presentations...

[Read more](https://blog.quelimaging.com/barth-reimbursement-strategy-2026-01)

[![QUEL Imaging Q800 reference target family](https://blog.quelimaging.com/hubfs/VISIMG-S_r0-0_REF-FAMILY-Q800.jpg)](https://blog.quelimaging.com/fda-draft-guidance)

[standardization](https://blog.quelimaging.com/tag/standardization)

### [FDA issues draft guidance on optical imaging drugs](https://blog.quelimaging.com/fda-draft-guidance)

![Picture of The QUEL Team](https://blog.quelimaging.com/hs-fs/hubfs/QUEL_Q.png?width=50&name=QUEL_Q.png) [The QUEL Team](https://blog.quelimaging.com/author/quel)

The FDA recently released [draft guidance for optical imaging drugs](https://www.fda.gov/media/184943/download), including an appendix dedicated...

[Read more](https://blog.quelimaging.com/fda-draft-guidance)

[![QUEL\_Q](https://blog.quelimaging.com/hs-fs/hubfs/QUEL_Q.png?width=100&height=102&name=QUEL_Q.png "QUEL_Q")](https://www.QUELimaging.com)

QUEL Imaging aims to build an ecosystem to accelerate and standardize methods for clinical translation of in vivo optical imaging technologies.

[linkedin-in icon](https://www.linkedin.com/company/quel-imaging/) [Follow us on Facebook](https://www.youtube.com/@quel-imaging) [Follow us on Facebook](https://www.instagram.com/quel_imaging/)

**Pages**

[Home](http://www.QUELimaging.com)

[Products](https://www.quelimaging.com/products)

[Shop](https://shop.QUELimaging.com)

[News](https://www.quelimaging.com/news)

[About](https://www.quelimaging.com/about)

**Resources**

[Blog](https://blog.quelimaging.com)

[Watch a Demo](https://www.youtube.com/channel/UCEQoMBcFibERa5dcsN9syEA)

[Contact Us](https://www.quelimaging.com/about/contact-us)

Copyright © 2026, QUEL Imaging